Contact this trialFirst, we need to learn more about you.
Antiandrogen
Enzalutamide + Indomethacin for Prostate Cancer
Recruiting1 awardPhase 1 & 2
Sacramento, California
This trial studies the effects of enzalutamide and indomethacin in treating prostate cancer that doesn't respond to hormone treatments, has returned, or has spread. Enzalutamide blocks male hormones that help cancer grow, while indomethacin reduces inflammation and may also fight cancer. The goal is to see if this combination can reduce cancer markers and improve patient outcomes.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service